Showing 11,901–11,920 of 17,974 drug recalls
Drug Recall
Terminated
Historical record Class II
LIPO-INJECTION W/METHYL B12 500 MCG/CARNITINE/NO VIT C W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, CARNITINE 25MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIPO-INJECTION W/METHYL B12 500 MCG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIPO-INJECTION W/METHYL B12 1 MG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-1MG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIPO-BOOST W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-52MG, METHYL, B12-500MCG, CARNITINE 50 MG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE 30MG/ML, In a) 3ML Vials and b) 5ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIPO B CYANO 1MG/ML W/PRES. (BENZYL ETOH 1%) METHIONINE 25MG, INOSITOL 50MG, CHOLINE CHL-50MG, CYANO B-12-100MCG, BENZYL ALCOHOL 1%/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIPO-INJECTION W/LIDOCAINE (PF), ASCORBIC ACID 50MG; B1-50MG; B2-5-PO4-5MG; B3-50MG B5-5MG, B6-5MG, CYANO B-12-100MCG, METHIONINE 12.5 MG, INOSITOL 25 MG, CHOLINE CL-25 MG, LIDCAINE 10 MG/ML, 2ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIPO #4 W/METHYL B12 500 MCG/ML/NO METHIONINE W/PRES (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;B3-30MG; B5-5MG;B6-5MG;METHYL B12 500 MCG; LIDOCAINE 10 MG; INOSITOL-25MG; CHOLINE CHL-25 MG/ML; 5ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
L-PHENYLALANINE 15MG/ML (PF), 50ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
L-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
L-CARNITINE 250MG/ML (PF), 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
L-CARNITINE 50MG/ML (PF), 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
L-CARNITINE 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
HYDROXY B12 1000MCG/ML IN NACL 0.9% (PF), 1ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
HYDROXY B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01%), 10ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
HYDROXY B12 5MG/ML IN NACL 0.9% (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Drug Recall
Terminated
Historical record Class II
HYDROGEN PEROXIDE 3% (PF), 5ML Vials, MEDAUS PHARMACY by Medaus, Inc.
Reason
Lack of Assurance of Sterility Recall initiated
May 13, 2016 Reported by FDA
July 20, 2016 Distribution
U.S. Nationwide, Japan, and New Zealand.
View recall →
Data last updated: September 26, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
